Earnings Call · Q2 FY2024·2024-08-07

Q2 24EPS +47.73%·Rev n/aQ1 24EPS +21.24%·Rev n/aQ4 23EPS -10.26%·Rev n/aQ3 23EPS -6.87%·Rev n/a⚠ consensus missing

Bionano Genomics, Inc. BNGO

David Holmes — Investor Relations or Corporate Communications

Erik Holmlin — Chief Executive Officer

Gülsen Kama

−7.0%1d on move date−9.3% vs SPY3d−9.3%5d−2.3%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more BNGO calls or request research access.

More BNGO calls Browse calls Request research access